| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 CNRS, UMR-5160, EFS, 240 avenue Emile Jeanbrau, 34094 Montpellier Cedex 5, France
2 Institut de Genetique Humaine, CNRS, UPR-1142, 141 rue de la Cardonille, 34396 Montpellier Cedex 5, France
3 Laboratoire d'Immunologie, Hôpital St-Eloi, 80 Avenue A. Fliche, 34295 Montpellier Cedex 5, France
Correspondence
Nadir Mechti
nadir.mechti{at}ibph.pharma.univ-montp1.fr
Interferons (IFNs) encode a family of secreted proteins that provide the front-line defence against viral infections. It was recently shown that ISG20, a new 3'
5' exoribonuclease member of the DEDD superfamily of exonucleases, represents a novel antiviral pathway in the mechanism of IFN action. In this report, it was shown that ISG20 expression is rapidly and strongly induced during human immunodeficiency virus type 1 (HIV-1) infection. In addition, it was demonstrated that the replication kinetics of an HIV-1-derived virus expressing the ISG20 protein (HIV-1NL4-3ISG20) was delayed in both CEM cells and peripheral blood mononuclear cells. No antiviral effect was observed in cells overexpressing a mutated ISG20 protein defective in exonuclease activity, suggesting that the antiviral effect was due to the exonuclease activity of ISG20. Paradoxically, despite the antiviral activity of ISG20 protein, virus rescue observed in HIV-1NL4-3ISG20-infected cells was not due to mutation or partial deletion of the ISG20 transgene, suggesting that the virus was able to counteract the cellular defences. In addition, HIV-1-induced apoptosis was significantly reduced in HIV-1NL4-3ISG20-infected cells suggesting that emergence of HIV-1NL4-3ISG20 was associated with the inhibition of HIV-1-induced apoptosis. Altogether, these data reflect the ineffectiveness of virus replication in cells overexpressing ISG20 and demonstrate that ISG20 represents a new factor in the IFN-mediated antiviral barrier against HIV-1.
These authors contributed equally to this work.
This article has been cited by other articles:
|
|
 |
|
  J. Tan, W. Qiao, J. Wang, F. Xu, Y. Li, J. Zhou, Q. Chen, and Y. Geng IFP35 Is Involved in the Antiviral Function of Interferon by Association with the Viral Tas Transactivator of Bovine Foamy Virus J. Virol., May 1, 2008; 82(9): 4275 - 4283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Peng, J. Zhu, Y. Hwangbo, L. Corey, and R. E. Bumgarner Independent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human Fibroblasts J. Virol., February 15, 2008; 82(4): 1934 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jiang, H. Guo, C. Xu, J. Chang, B. Gu, L. Wang, T. M. Block, and J.-T. Guo Identification of Three Interferon-Inducible Cellular Enzymes That Inhibit the Replication of Hepatitis C Virus J. Virol., February 15, 2008; 82(4): 1665 - 1678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, C. W. Burke, K. D. Ryman, and W. B. Klimstra Identification and Characterization of Interferon-Induced Proteins That Inhibit Alphavirus Replication J. Virol., October 15, 2007; 81(20): 11246 - 11255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Wahl, T. Greenwell-Wild, and N. Vazquez HIV accomplices and adversaries in macrophage infection J. Leukoc. Biol., November 1, 2006; 80(5): 973 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Okumura, G. Lu, I. Pitha-Rowe, and P. M. Pitha Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15 PNAS, January 31, 2006; 103(5): 1440 - 1445. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
